Amarin: Complaint Of Unfair Competition From Omega-3 Supplements 'Ripe' For Supreme Court

As Amarin did in complaint to ITC for a fair trade investigation and appeal to Federal Circuit. it framed its petition for a writ of certiorari to Supreme Court as a compliant pharma firm that invested in research for approval of a drug asking federal agencies to enforce laws to stem competition from products it claims are labeled as supplements but should be deemed unapproved drugs.

US Supreme court building with 1st statue on left

More from Regulation

More from Policy & Regulation